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Abstract
Background: Substantial decline in malaria transmission, morbidity and mortality has been reported in
several countries where new malaria control strategies have been implemented. In Gabon, the national
malaria policy changed in 2003, according to the WHO recommendations. The trend in malaria morbidity
was evaluated among febrile children before and after their implementation in Libreville, the capital city of
Gabon.
Methods: From August 2000 to December 2008, febrile paediatric outpatients and inpatients, under 11
years of age, were screened for malaria by microscopic examination at the Malaria Clinical Research Unit
(MCRU) located in the largest public hospital in Gabon. Climatic data were also collected.
Results: In total, 28,092 febrile children were examined; those under five years always represented more
than 70%. The proportion of malaria-positive slides was 45% in 2000, and declined to 15% in 2008. The
median age of children with a positive blood smear increased from 24(15-48) to 41(21-72) months over
the study period (p < 0.01). Rainfall patterns had no impact on the decline observed throughout the study
period.
Conclusion: The decrease of malaria prevalence among febrile children during the last nine years is
observed following the introduction of new strategies of malaria cases management, and may announce
epidemiological changes. Moreover, preventive measures must be extended to children older than five
years.
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Malaria has, for a long time, been the major cause of
febrile illness in sub-Saharan Africa, where 80% of the
247 million cases were reported in 2006 [1]. The appear-
ance of multidrug-resistance Plasmodium falciparum has
led to the introduction of new control strategies. Insecti-
cide-treated bed nets (ITNs), along with prompt and effec-
tive treatment of clinical malaria cases, intermittent
preventive treatment in pregnant women, and indoor
residual spraying, are now being deployed widely across
Africa with increasing amounts of coverage achieved [2-
4]. There is growing evidence documenting a substantial
decline in malaria transmission, morbidity and mortality
in several countries where these interventions have been
implemented including areas with high levels of transmis-
sion [5-8]. One of the major challenges for the effective
monitoring and evaluation of the impact of malaria con-
trol tools is to provide epidemiological informations in
endemic areas such as Gabon. Throughout this country,
infections with P. falciparum accounted for 30% to 50% of
the consultations of children with fever between 1980s
and 1990s [[9-11], Kombila et al, unpublished data].
Resistance to chloroquine appeared in the 1980s and rose
to 100% since 2001 [12-14]. In 2003, Gabonese Ministry
of Health changed the malaria national policy to follow
the WHO 2000 recommendations [15]. Artemisinin
based combination therapies (ACTs) were adopted as
first- and second-line treatment for uncomplicated
malaria, and along with ITNs and sulfadoxine-pyrimeth-
amine for intermittent preventive treatment (IPTp-SP)
were freely available in all public health centres of country
since 2005, for children under five years old and pregnant
women. Reduced malaria prevalence in pregnant women
was observed in Libreville and Lambaréné following IPTp-
SP implementation [16]. In this study, the trend in
malaria morbidity was evaluated among febrile children,
over a nine-year period, in the largest public hospital of
Libreville, the capital city of Gabon.
Methods
Study site and population
This prospective and observational study was conducted
from August 2000 to December 2008 in Libreville, the
capital city of Gabon, where the climate is equatorial. In
this urban area, malaria is predominantly caused by P. fal-
ciparum. The population of Libreville was estimated to be
537,540 inhabitants in 2006, with children under five
years of age representing 16%.
The Malaria Clinical Research Unit (MCRU) is a branch of
the Department of Parasitology of the Medicine Faculty,
located in the Centre Hospitalier de Libreville (CHL), the
largest public hospital in Gabon. At MCRU, all febrile pae-
diatric outpatients and inpatients, aged less than 11 years
old, were prospectively screened for malaria. In this unit,
children routinely benefit for free malaria diagnosis based
on microscopic examination. Temperature, history of
fever, age, sex, and location were collected prospectively.
Malaria diagnosis
Throughout the study period, a thick blood film was done
for each patient. Blood slides were processed according to
the Lambaréné procedure, which is described elsewhere
[17]. Slides were considered negative if no asexual blood
stages of parasites and gametocytes were seen in 100 oil-
immersion fields. Quality control of the blood smears was
performed: a second microscopist, blinded to the results
of the first reading, read the slides. In case of disagree-
ment, slides were controlled by a third microscopist and
the mean of the two closest readings of parasitaemia was
taken. The case definition of malaria was any febrile child
with slide-confirmed parasites.
Rainfall patterns
Monthly rainfall data of Libreville for the last decade were
obtained from the meteorological services of the Agency
for Air Navigation Safety in Africa and Madagascar
(ASECNA).
Data analysis
Demographic and laboratory data were recorded and
given to the data manager. Data were entered and cleaned
using Epi-info version 3.3.2 (February 9, 2005 CDC
Atlanta) and were analysed with STATA version 10 (Stata
Corp, College station, USA). Medians with interquartile
ranges (IQR) of age and geometric means of parasite den-
sities (GMPD) are presented. Differences between groups
were assessed using Pearson's chi-squared or Fisher's exact
tests for proportions. For ordinal outcomes, the linear
trend test (Cochran-Armitage test for trend) was used. The
association between age and risk of malaria by year was
assessed using odds ratio and the 95% confidence interval
(OR (95%CI)). Linear regression was applied to test the
significance of decreases for log-transformed data. To take
into account the effect of auto-correlated observations
and the season disturbances, an ARMAX model was built
including covariates. We postulated a straightforward
relationship between proportion of malaria cases and the
monthly rainfall average measured by 20-point first-order
moving average that was applied to filter seasonal varia-
tion and highlight the long-term movements in the data.
Deviations in monthly rainfall were examined by compar-
ing monthly values of the parameters (malaria cases, rain-
fall, time series data) obtained during the study period (9
years).
The significance level of all comparison was set at 0.05. All
reported p-values are two-tailed.Page 2 of 7
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Prevalence of febrile cases
During the nine-year study period, slides from 28,092
febrile children were examined at the MCRU. The number
of children screened showed two peaks, in 2002 (n =
4867) and in 2008 (n = 4684). There was a decrease in the
yearly number of consultations for fever from 2002 to
2005, followed by a significant increase until 2008 (p <
0.01, Cochran-Armitage test for trend) (Table 1).
The median (IQR) age of children consulting for fever was
globally of 24(12-48) months. This did not significantly
change from one year to another over the nine years
(Table 1). Overall, children younger than five years repre-
sented 76% of the screened patients; this proportion was
nearly the same over the surveillance period (Table 1).
More than 55% of the febrile patients screened each year
at MCRU were aged 0 to 35 months.
Malaria prevalence
There was a linear decrease in the annual number of
malaria cases, from 1,785 in 2002 to 359 in 2007 with a
slight increase in 2008 (p < 0.01, Cochran-Armitage test
for trend). In 2000, the proportion of febrile illness due to
malaria was 45%; this proportion declined to 12% in
2007 and 15% in 2008.
Age and malaria
The median (IQR) age of children with a positive blood
smear significantly increased from 24(15-48) to 41(21-
72) months over the study period (p < 0.01). In 2000, par-
asite prevalence was highest and the median age of
patients with positive slides the lowest (Figure 1). The
median age of patients with malaria negative slides did
not fluctuate (24(12-48)) over the time. The lowest prev-
alence of malaria throughout the study period was found
among the 0-23 months old patients (Figure 2). The pro-
portion of malaria cases in the febrile children increased
with age until 47 months (p < 0.01, Cochran-Armitage test
for trend); from four years old, the proportion of malaria
cases was similar in the different age groups (Figure 2).
The study population was grouped into those less than
five years and the oldest (Table 1). In children younger
than five years old, the prevalence of malaria decreased
significantly in 2001 (26%), compared to the year 2000 (p
< 0.01). A relative increase in malaria cases of 10% was
observed between 2001 and 2002, followed by a drop of
about two third in 2007 (10%) and 2008 (13%) (p < 0.01,
Cochran-Armitage test for trend). In older children (5-10
years), the proportion of malaria cases was significantly
higher compared to the youngest; the risk of having
malaria was 1.2 to 2.0 in older patients than younger ones
(Table 1).
According to the paediatric ward, data were compared
between inpatients group (n = 15299) and outpatients
group (n = 7502); origin was not known for 5291 chil-
dren. Between 2000 and 2005, the proportion of malaria
cases among children aged less than 24 months was
always higher in the inpatients group (25-35%) compared
to the outpatients (11-23%) (p < 0.01). From 2006, the
same difference was only observed for patients aged 96 to
120 months old ((p < 0.02). During the study period, the
median age did not significantly vary among the infected
inpatients, ranging from 18 to 24 months old; whereas in
the infected outpatients group, it ranged from 21 to 40
months (p < 0.01)
Parasite densities
Parasitaemia ranged from 14/μL to 1,611,408/μL. The
GMPD did not vary significantly over the study period,
and ranged from 6,800 p/μL in 2000 to 7,512 p/μL in
2008. Depending on the age, the GMPD was slightly
higher in children less than five years old (6751/μL to
9,779/μL) than in children aged 5-10 years old (3,593/μL
to 6,951/μL). No difference was observed when compar-
Table 1: Proportion of malaria cases according to age (between 2000 to 2008)
2000 2001 2002 2003 2004 2005 2006 2007 2008
Number of children 889 3525 4867 4133 2932 1174 2172 3116 4684
Age, Median(IQR)a, months 24(13-48) 24(12-48) 24(13-54) 24(12-48) 24(12-54) 24(12-48) 24(12-48) 24(12-60) 24(12-48)
Proportion with Malaria 45% 27% 36.7% 36.4% 30.0% 24.5% 21.0% 12.0% 15.0%
Children (0- <5 years), N(%) 699 (79%) 2795 (79%) 3656 (75%) 3159 (76%) 2190 (75%) 1347 (75%) 1655 (76%) 2327 (75%) 3630 (78%)
-proportion with malaria 45% 26% 36% 34% 28% 21% 19% 10% 13%
Children (5-10 years), N,(%) 190 (21%) 730 (22%) 1211 (25%) 974 (24%) 742 (25%) 427 (25%) 517 (24%) 789 (25%) 1054 (23%)
- proportion with malaria 46% 31% 40% 43% 37% 35% 27% 16% 23%
OR (95%CI)b for malaria risk
- children 
(0 - <5  years)
Reference Reference Reference Reference Reference Reference Reference Reference Reference
- children 
(5-10 years)
1.0 (0.7-1.4) 1.3 (1.1-1.5) 1.2 (1.1-1.3) 1.5 (1.3-1.7) 1.6 (1.3-1.8) 2.0 (1.6-2.6) 1.5 (1.2-1.9) 1.7 (1.4-2.2) 2.0 (1.6-2.3)
p-value 0.91 0.004 0.02 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
a: interquartile ranges (25th and 75th percentiles); b: Children less than five years served as reference; N: numberPage 3 of 7
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(results not shown).
Rainfall and malaria prevalence
Rainfall patterns were similar throughout the study
period. June, July and August were the driest months with
recorded rainfalls of 0 to 85 mm, except for the years 2000
and 2006 (Figure 3). The rest of the months were gener-
ally rainy with the wettest period from October to Decem-
ber (330-400 mm).
Monthly malaria prevalence data showed that there was a
slight decrease in the proportion of positive slides from
February to May, with a continuous increase between May
and October (Figure 3). However, a comparison of the
proportions of malaria cases during the rainy (mean prev-
alence obtained between September and May) and the dry
season (mean prevalence obtained between June and
August) did not show any difference over the study
period. Indeed, analysis of time series auto-correlation on
de-seasonalized data showed that there was an absence of
correlation between means of monthly rainfall, with an
autocorrelation coefficient of 0.48 (95%CI: -1.81-0.86)
(standard error 0.68) (p = 0.48). Rainfall had no effect on
the intercept of the trends in the proportion of malaria
cases observed during the study period (Table 2).
Discussion
Understanding the local epidemiology of malaria is essen-
tial to design the best methods to control the disease. This
prospective study assessed the evolution of malaria mor-
bidity in an urban hospital care seeking febrile children of
Gabon, and showed that the pattern of P. falciparum infec-
tion has changed from 2000 to 2008. The proportion of
malaria positive slides among febrile children seen at hos-
pital strongly declined and was accompanied by a rise in
the age of children with malaria. This follows a twenty-
year period during which the prevalence of malaria was
29% in 1980, and had increased to more than 40% in
2000 [18]. The evolution of the proportion of malaria
cases, diagnosed using the same standardized method,
did not follow the yearly recorded number of febrile
patients; whatever the number of children seen at MCRU,
the number of malaria cases consistently decreased over
the time. The fact that the proportion of non malaria cases
significantly rose during the study period while a signifi-
cant downward trends in malaria cases was observed, sug-
gests that this decline is specific to malaria.
The decrease in the prevalence of malaria started in 2001,
probably due to several factors. Climatic data were ana-
lysed; rainfall patterns remained constant throughout the
nine years of observation and had no impact on the dras-
PBS: proportion of malaria positive blood smearsFigure 1
PBS: proportion of malaria positive blood smears.
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positive blood smears did not show any seasonal varia-
tion. Numerous interventions occurred in the country
during the study period. Indeed, at the beginning of the
study, chloroquine was the first line and the main treat-
ment for mild malaria, despite a well documented resist-
ance above 90% [13,14]. Consecutively, a change in
malaria treatment behaviour was observed; between 2000
and 2006, artemisinin derivatives based monotherapies
and artemether-lumefantrine combination (from 2002),
that were widely available in the country, became the
most frequently antimalarials prescribed. In 2003, artesu-
nate-amodiaquine and artemether-lumefantrine were
chosen as first and second line treatments for uncompli-
cated malaria [15]. This policy decision, supported by the
Global Fund, led to the deployment of free distribution of
ACTs and ITNs in 2005 in public health facilities, target-
ing children younger than five years old. Bednet impreg-
Age distribution of the proportion of malaria cases by year among children under 11 years (from 2000 to 2008)Figure 2
Age distribution of the proportion of malaria cases by year among children under 11 years (from 2000 to 
2008).
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Monthly distribution of the proportion of malaria positive blood smears and mean rainfallFigure 3
Monthly distribution of the proportion of malaria positive blood smears and mean rainfall.
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reached 49.8% in 2006 and 57% in 2008 [[1], Malaria
control program, unpublished data]. More than two mil-
lions of ACTs packs have been distributed in public health
centres from 2006 to 2008. This can be surprising when
considering that the target population comprised 272,000
children less than five years; but presumptive treatment of
fever with an antimalarial drug is still frequent in Gabon,
and ACTs are freely provided to the patients, irrespective
of their age [19].
The good efficacy of artemisinin derivatives based thera-
pies, which was evaluated to be higher than 95% in 2005,
and the use of ITNs may have contributed, independently
or in association, to the reduction of the morbidity of the
disease as demonstrated elsewhere [8,20-23].
Throughout the nine-year study period, the burden of
febrile illness remained highest among children under
five years old. However, the median age of children with
malaria significantly increased, as the prevalence of the
infection declined. From 2001, children over five years of
age were more likely to have malaria, suggesting a higher
exposure (though that most of them do not benefit from
free ITNs in Libreville) or a delayed acquisition of immu-
nity, as observed by other authors [24-27]. However, this
changing age pattern was not observed in the inpatient
group, then, the severity of the disease remained confined
to the youngest as reported elsewhere [3,6,28].
The decline of malaria prevalence and the age shift
towards the older children may indicate a change in the
dynamics of malaria epidemiology in Libreville. It has
been reported that the age at which patients experience
malaria increases with a decline in exposure, and may pre-
cede changes in malaria transmission [3,7,25]. Further-
more, urbanization is extending in Libreville, creating a
hostile environment to anophelinae vector development.
This study was a health facility-based survey, probably not
representative of the situation in the entire country; in sev-
eral private health centres and rural areas, laboratory and/
or well-trained microscopists are lacking. Moreover, the
function of the MCRU in the CHL is to provide results of
freely available microscopic diagnosis of malaria to clini-
cians working in the different wards, information on
malaria clinical presentations, outcomes and treatments
are missing.
Conclusion
The proportion of malaria among febrile children has
decreased during the last nine years, probably due to the
impact of the utilization of more effective antimalarial
drugs, artemisinin derivatives based therapies. After the
wide-scale introduction of new effective prevention and
disease management strategies, this decline was more pro-
nounced. All these interventions are likely to be the main
possible contributing factors to the observed malaria
changes. Preventive measures must be further imple-
mented and extended to older children. Studies on the
prevalence of malaria in other parts of the country and
record of entomological data are needed to characterize
the transmission levels in Gabon.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
The study was initiated by MK and PGK; and conducted
by MK with contribution of all authors. MKBA and
DPMM interpreted the data and drafted the manuscript.
Data were analysed by MKBA and EK. MMM, EBN, TP,
ADE, MPM, EI, EEE and MCRU team participated to the
field study. All authors revised and approved the final
manuscript.
Acknowledgements
We are grateful to the parents, children, the manager; the physicians of the 
Centre Hospitalier de Libreville and the MCRU team i.e. Pascal Christian 
Nze, Nestor Obiang-Bekale, Pacome Mouidi, Franckie Mbadinga, Edith 
Flore Bourobou.
References
1. References World Health Organization: World malaria report
2008.  . who/htm/gmp/2008.1
2. Malaria in children: progress and intervention coverage
[http://www.unicef.org/health/files/MalariaOct6forweb_final.pdf]
3. Schellenberg D, Menendez C, Aponte J, Guinovart C, Mshinda H, Tan-
ner M, Alonso P: The changing epidemiology of malaria in
Ifakara town, southern Tanzania.  Trop Med Int Health 2004,
9:68-76.
4. Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M,
Brasseur P: Implementation of intermittent preventive treat-
ment in pregnancy with sulphadoxine/pyrimethamine (IPTp-
SP) at a district health centre in rural Senegal.  Malar J 2008,
7:234.
Table 2: Results of time series analysis
Parameters Coefficient SE t-stat P-value 95%CI
Intercept 26.84 17.22 1.56 0.12 -6.9 60.60
Non malaria cases 0.24 0.04 5.96 < 0.01 0.16 0.32
Rainfall 0.67 1.90 -0.35 0.73 -4.39 3.06
SE: standard errorPage 6 of 7
(page number not for citation purposes)
Malaria Journal 2009, 8:300 http://www.malariajournal.com/content/8/1/300Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
5. Impact of long-lasting insecticidal-treated nets (LLINs) and
artemisin-based combination therapies (ACTs) measured
using surveillance data in four African countries   [http://
apps.who.int/malaria/docs/ReportGFImpactMalaria.pdf]
6. Diallo DA, Cousens SN, Cuzin-Ouattara N, Nebié I, Ilboudo-Sanogo
E, Esposito F: Child mortality in a West African population
protected with insecticide-treated curtains for a period of up
to 6 years.  Bull World Health Organ 2004, 82:85-91.
7. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh
K, Snow RW: The decline in paediatric malaria admissions on
the coast of Kenya.  Malar J 2007, 6:151-61.
8. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R,
Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F,
Abdulla S, Montgomery SM, Kaneko A, Björkman A: Impact of
artemisinin-based combination therapy and insecticide-
treated nets on malaria burden in Zanzibar.  PLoS Med 2007,
4:1784-90.
9. Richard-Lenoble D, Kombila M, Chandenier J, Gay F, Billiault X,
Nguiri C, Martz M, Boyer F, Bauzou M: Paludisme au Gabon 2.
Evaluation des prévalences parasitaires qualitatives et quan-
titatives sur l'ensemble du pays en milieu scolaire et présco-
laire.  Bull Soc Pathol Exot Filiales 1987, 80:532-42.
10. Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdor-
fer WH: Malaria epidemiology in the province of Moyen
Ogoov, Gabon.  Trop Med Parasitol 1995, 46:77-82.
11. Dzeing-Ella A, Nze Obiang PC, Tchoua R, Planche T, Mboza B,
Mbounja M, Muller-Roemer U, Jarvis J, Kendjo E, Ngou-Milama E,
Kremsner PG, Krishna S, Kombila M: Severe falciparum malaria
in Gabonese children: clinical and laboratory features.  Malar
J 2005, 4:1-7.
12. Richard-Lenoble D, Kombila M, Martz M, Lefèvre B, Chandenier J,
Gay F, Billiault X, Thérizol-Ferly M: Evolution de la chloroquino-
résistance à Plasmodium falciparum au Gabon entre 1984 et
1987-88 (étude in vivo en milieu scolaire).  Ann Soc Belg Med
Trop 1989, 69:113-9.
13. Pradines B, Mabika Mamfoumbi M, Parzy D, Owono Medang M, Leb-
eau C, Mourou Mbina JR, Doury JC, Kombila M: In vitro susceptibil-
ity of Gabonese wild isolates of Plasmodium falciparum to
artemether, and comparison with chloroquine, quinine,
halofantrine and amodiaquine.  Parasitology 1998, 117:541-5.
14. Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ram-
harter M, Wernsdorfer WH, Kremsner PG: Reassessment of the
resistance of Plasmodium falciparum to chloroquine in
Gabon: implications for the validity of tests in vitro vs. in vivo.
Trans R Soc Trop Med Hyg 2002, 96:660-3.
15. Ministère de Santé: Rapport de l'atelier national de consensus
sur les perspectives thérapeutiques du paludisme.  Programme
national de lutte contre le paludisme, Gabon 2003:13-14.
16. Ramharter M, Schuster K, Bouyou-Akotet MK, Adegnika AA, Schmits
K, Mombo-Ngoma G, Agnandji ST, Nemeth J, Afène SN, Issifou S,
Onnas IN, Kombila M, Kremsner PG: Malaria in Pregnancy
Before and After the Implementation of a National IPTp
Program in Gabon.  Am J Trop Med Hyg 2007, 77:418-22.
17. Planche T, Krishna S, Kombila M, Engel K, Faucher JF, Ngou-Milama E,
Kremsner PG: Comparison of methods for rapid laboratory
assessment of children with malaria.  Am J Trop Med Hyg 2001,
65:599-602.
18. Richard-Lenoble D, Kombila M, Chandenier J, Engohan E, Gannier M,
Dubourg C: Paludisme au Gabon 1. Etude de 500 enfants
fébriles à Libreville.  Bull Soc Pathol Exot Filiales 1986, 79:284-7.
19. Mawili-Mboumba DP, Bouyou Akotet MK, Ngoungou EB, Kombila M:
Evaluation of rapid diagnostic tests for malaria case manage-
ment in Gabon.  Diag Microb Infect Dis 2009 in press.
20. Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gil-
bos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leeming-
sawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F:
Deployment of early diagnosis and mefloquine-artesunate
treatment of falciparum malaria in Thailand: the Tak
Malaria Initiative.  PLoS Med 2006, e183:856-64.
21. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E,
Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL:
Effect of artemether-lumefantrine policy and improved vec-
tor control on malaria burden in KwaZulu-Natal, South
Africa.  PLoS Med 2005, e330:1123-34.
22. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini
U, Ogbamariam A, Kosia A, Gebremichael A, Gunawardena D, Ghe-
brat Y, Okbaldet Y: A steep decline of malaria morbidity and
mortality trends in Eritrea between 2000 and the effect of
combination of control methods.  Malar J 2004, 5:33-44.
23. Bouyou-Akotet MK, Nzenze-Afène S, Mabika-Mamfoumbi M, Pemba
M, Doumbo OK, Kombila M: Evaluation de l'efficacité et de la
tolérance de l'Arsucam®, de l'Artequin® et du Coartem®
dans le traitement du paludisme non compliqué de l'enfant.
Bull Med Owendo 2006, 11:70-75.
24. Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM,
Musyoki JN, Bull PC, Marsh K: Analysis of immunity to febrile
malaria in children that distinguishes immunity from lack of
exposure.  Infect Immun 2009, 77:1917-23.
25. O'Meara WP, Mwangi TW, Williams TN, McKenzie FE, Snow RW,
Marsh K: Relationship between exposure, clinical malaria, and
age in an area of changing transmission intensity.  Am J Trop
Med Hyg 2008, 79:185-91.
26. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ,
Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T,
Bojang KA, Whittle HC, Greenwood BM, Conway DJ: Changes in
malaria indices between 1999 and 2007 in The Gambia: a ret-
rospective analysis.  Lancet 2008, 372:1545-54.
27. Clarke SE, Brooker S, Njagi JK, Njau E, Estambale B, Muchiri E, Mag-
nussen P: Malaria morbidity among school children living in
two areas of contrasting transmission in western Kenya.  Am
J Trop Med Hyg 2004, 71:732-8.
28. Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW: Age
patterns of severe paediatric malaria and their relationship
to Plasmodium falciparum transmission intensity.  Malar J 2009,
8:4-14.Page 7 of 7
(page number not for citation purposes)
